Apomorphine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for apomorphine hydrochloride and what is the scope of patent protection?
Apomorphine hydrochloride
is the generic ingredient in three branded drugs marketed by Sunovion Pharms Inc, Mdd Us, and Sage Chems, and is included in three NDAs. There are nineteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.Apomorphine hydrochloride has two hundred and forty-nine patent family members in twenty-five countries.
There are three drug master file entries for apomorphine hydrochloride. Three suppliers are listed for this compound.
Summary for apomorphine hydrochloride
International Patents: | 249 |
US Patents: | 19 |
Tradenames: | 3 |
Applicants: | 3 |
NDAs: | 3 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Clinical Trials: | 47 |
Patent Applications: | 5,638 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for apomorphine hydrochloride |
What excipients (inactive ingredients) are in apomorphine hydrochloride? | apomorphine hydrochloride excipients list |
DailyMed Link: | apomorphine hydrochloride at DailyMed |
Recent Clinical Trials for apomorphine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
William Ondo, MD | Phase 4 |
Sunovion | Phase 4 |
Rennes University Hospital | Phase 4 |
Pharmacology for apomorphine hydrochloride
Drug Class | Dopaminergic Agonist |
Mechanism of Action | Dopamine Agonists |
Medical Subject Heading (MeSH) Categories for apomorphine hydrochloride
US Patents and Regulatory Information for apomorphine hydrochloride
Expired US Patents for apomorphine hydrochloride
International Patents for apomorphine hydrochloride
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 101316579 | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions | See Plans and Pricing |
European Patent Office | 3735988 | FILMS SUBLINGUES (SUBLINGUAL FILMS) | See Plans and Pricing |
Mexico | 2013006911 | PELICULAS SUB-LINGUALES. (SUBLINGUAL FILMS.) | See Plans and Pricing |
Canada | 2456234 | INSTRUMENTS OPTIQUES ACCORDABLES (TUNABLE OPTICAL INSTRUMENTS) | See Plans and Pricing |
Austria | 536868 | See Plans and Pricing | |
Canada | 2544776 | FILMS A BASE D'OXYDE DE POLYETHYLENE ET SYSTEMES D'ADMINISTRATION DE MEDICAMENTS EN ETANT FAITS (POLYETHYLENE OXIDE-BASED FILMS AND DRUG DELIVERY SYSTEMS MADE THEREFROM) | See Plans and Pricing |
Canada | 2821756 | FILMS SUBLINGUAUX (SUBLINGUAL FILMS) | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.